The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
“FIRST DOMESTIC PRODUCTION OF MOLY99 BY NORTH STAR NUCLEAR MEDICINE” mentioning the U.S. Dept. of Energy was published in the Extensions of Remarks section on pages E327 on March 15, 2018.
The Department oversees energy policies and is involved in how the US handles nuclear programs. Downsizing the Federal Government, a project aimed at lowering taxes and boosting federal efficiency, said the Department's misguided energy regulations have caused large losses to consumers for decades.
The publication is reproduced in full below:
FIRST DOMESTIC PRODUCTION OF MOLY99 BY NORTH STAR NUCLEAR MEDICINE
_____
HON. MARK POCAN
of wisconsin
in the house of representatives
Thursday, March 15, 2018
Mr. POCAN. Mr. Speaker, on February 8, 2018, the U.S. Food and Drug Administration (FDA) approved the first domestic production of Moly99 by North Star Nuclear Medicine, which is located in Beloit, Wisconsin. Moly99 is the key substance used in 50,000 daily procedures using nuclear medicine to diagnose a variety of illness.
For many years, the United States has been dependent on foreign sources using nuclear fission offshore. These reactors, located in Canada, the Netherlands, South Africa, and Australia, are old and have been the subject of many disruptions of supply causing shortages.
Working with help from the U.S. Department of Energy and the cooperation of the FDA, North Star has developed a system to produce Moly99 without any use of uranium, resulting in little waste and no nuclear waste.
I want to congratulate George Messina, North Star's CEO, and his 130 employees, located in the cities of Beloit and Madison, on their achievement. Nuclear medicine is vital to the diagnosis and cure of many diseases. Thanks to the dedication and perseverance of this Wisconsin company, consumers will have access to the first domestic supply of this much needed medicine.
____________________
